Ftse Mib
34.490,71
0,07%
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
NASDAQ
16.920,79
1,10%
Bitcoin
69.036,83
-0,33%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC RegeneRX Biopharmaceuticals Inc (CE) (RGRX) RegeneRX Biopharmaceuticals Inc (CE) (RGRX) Notizie

RGRX

RegeneRX Biopharmaceutic... (CE) (RGRX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:RGRX
DataOraFonteTitoloSimboloCompagnia
14/08/202322:01Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
07/08/202321:57Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
11/07/202323:13Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
06/07/202322:35Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
06/07/202322:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
26/06/202312:01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
21/06/202312:03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
15/05/202322:25Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
11/04/202322:32Edgar (US Regulatory)Annual Report (10-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/05/202223:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
18/10/202112:05Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
17/08/202116:32Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/07/202122:16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
09/02/202100:29Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
16/10/202022:17Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
18/08/202012:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
10/09/201923:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
07/03/201920:15Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
01/03/201922:42Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
24/10/201812:02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
23/10/201812:05Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
12/12/201718:35Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
14/08/201723:10Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
03/08/201612:03Edgar (US Regulatory)(DEL AM)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
30/03/201623:17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
29/12/201419:42Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
01/04/201422:43Edgar (US Regulatory)Semi-annual Report (management Company) (nsar-a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
01/04/201422:43Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
01/04/201422:42Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
01/04/201422:37Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:RGRX

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
BAMI
Banco BPM
BIT
PRY
Prysmian
BIT
BPE
Bper Banca
BIT
TITR
Telecom Italia
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network